Loss of immune homeostasis in AIH patients with impaired AHR activity was attributed to increased expression of the AHR repressor AHRR and high levels of HIF-1α, a competitive binding partner for ARNT, thereby inhibiting AHR signal transduction and consequently CD39 in Tregs and Th17 cells in human AIH. Here, ENTPD1 is linked to autoimmune hepatitis.